| Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression (NCT06227325) | Henan Cancer Hospital | 2024-02-01 |
| Clinical Evidence Based and TCM Phenotype Group Study of Zhilong Huoxue Tongyu Capsule in the Treatment of Stable Angina Pectoris of Coronary Heart Disease (Qi Deficiency and Blood Stasis Syndrome) (NCT06709638) | Jiang Hanmei | 2024-02-01 |
| Pain Managment in Preterm Neonates (NCT07148882) | Ain Shams University | 2024-02-01 |
| Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne (NCT06311890) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2024-02-01 |
| Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients (NCT06032052) | Hubei Cancer Hospital | 2024-02-01 |
| Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser (NCT06239324) | Egymedicalpedia | 2024-02-01 |
| Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer (NCT06066216) | Fujian Cancer Hospital | 2024-02-01 |
| Extended Letrozole Protocol Versus Letrozole Plus Inositol for Induction of Ovulation in Letrozole Resistant PCOS Women (NCT07635082) | Eman Basuni Ebrahim Mowad | 2024-02-01 |
| Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma (NCT05846724) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2024-02-01 |
| Pulmonary Expansion Device in Tracheostomized Patients Therapies in Tracheostomized Patients (NCT06075381) | Fundacion Clinica Valle del Lili | 2024-02-01 |
| A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD (NCT06309277) | Gilgamesh Pharmaceuticals | 2024-02-01 |
| JAK Inhibitor in Acquired Hemophagocytic synDrome in the Intensive Care Unit (NCT06244862) | Assistance Publique - Hôpitaux de Paris | 2024-02-01 |
| Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure. (NCT05645887) | Albimmune SL | 2024-02-01 |
| A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL (NCT06220487) | Nanfang Hospital, Southern Medical University | 2024-02-01 |
| Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis (NCT06811025) | Beijing Chest Hospital | 2024-02-01 |
| Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer (NCT06221462) | Ningbo No.2 Hospital | 2024-02-01 |
| SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases (NCT06210438) | Fudan University | 2024-02-01 |
| Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients (NCT06297369) | Ain Shams University | 2024-02-01 |
| Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients (NCT06234072) | Shenzhen University General Hospital | 2024-02-01 |
| Access-H20: Sensor-driven Smart Faucet Related Study (NCT07603258) | Old Dominion University | 2024-02-01 |
| Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients (NCT06280495) | Sun Yat-sen University | 2024-02-01 |
| Chemo-free BRCA-targeted Neoadjuvant Strategy (NCT05209529) | European Organisation for Research and Treatment of Cancer - EORTC | 2024-02-01 |
| The Therapeutic Effect of Thalidomide in Syringomyelia (NCT06268093) | Xuanwu Hospital, Beijing | 2024-02-01 |
| Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET) (NCT07607197) | Hospital Universitari Vall d'Hebron Research Institute | 2024-02-01 |
| Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE) (NCT06314087) | The University of Hong Kong-Shenzhen Hospital | 2024-01-31 |
| Pediatric Oncology Nutrition Intervention Trial (NCT06175273) | Corey Hawes | 2024-01-31 |
| Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy (NCT06238648) | Academic and Community Cancer Research United | 2024-01-31 |
| Safety and Efficacy of Empagliflozin in Hemodialysis (NCT05786443) | NYU Langone Health | 2024-01-31 |
| Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration (NCT06116890) | Kyowa Kirin Co., Ltd. | 2024-01-31 |
| Study of AZD9829 in CD123+ Hematological Malignancies (NCT06179511) | AstraZeneca | 2024-01-31 |
| Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis (NCT06278350) | InventisBio Co., Ltd | 2024-01-31 |
| Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA (NCT06091085) | Brigham and Women's Hospital | 2024-01-31 |
| A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults (NCT06237049) | Pfizer | 2024-01-31 |
| PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications (NCT06161519) | National Cancer Institute (NCI) | 2024-01-31 |
| A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors (NCT06237881) | M.D. Anderson Cancer Center | 2024-01-31 |
| Proglumide and Chemotherapy for Metastatic Pancreatic Cancer (NCT05827055) | Georgetown University | 2024-01-31 |
| A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor (NCT06758557) | Huabo Biopharm Co., Ltd. | 2024-01-31 |
| AMT-253 in Patients With Advanced Solid Tumours (NCT06209580) | Multitude Therapeutics Inc. | 2024-01-31 |
| Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer (NCT06015724) | Georgetown University | 2024-01-31 |
| A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD (NCT06236880) | Gilgamesh Pharmaceuticals | 2024-01-31 |
| Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. (NCT06236724) | M.D. Anderson Cancer Center | 2024-01-31 |
| Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis (NCT06811012) | Beijing Chest Hospital | 2024-01-31 |
| SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia (NCT06280690) | Leiden University Medical Center | 2024-01-31 |
| Endorectal Brachytherapy for Rectal Cancer (NCT05591534) | University Hospital, Bordeaux | 2024-01-31 |
| Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC (NCT06202014) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-01-31 |
| Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer (NCT06341530) | The First Affiliated Hospital of Zhengzhou University | 2024-01-31 |
| Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma (NCT05960773) | National Cancer Institute (NCI) | 2024-01-31 |
| Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT05571059) | Cumberland Pharmaceuticals | 2024-01-31 |
| The Role of Brain Dopamine in Chronic Pain (NCT05285683) | University of Rochester | 2024-01-31 |
| Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy (NCT06293287) | Zhongshan Hospital (Xiamen), Fudan University | 2024-01-31 |
| A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV (NCT06206720) | Vigonvita Life Sciences | 2024-01-31 |
| Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM (NCT06543069) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-01-31 |
| Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma (NCT06199271) | Zhongzheng Xiang | 2024-01-31 |
| A Study of Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma (NCT06196775) | Harbin Medical University | 2024-01-31 |
| COMMETS- Combination MCI Metabolic Syndrome (NCT06072963) | Rutgers, The State University of New Jersey | 2024-01-30 |
| Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care (NCT04824144) | Bruyère Health Research Institute. | 2024-01-30 |
| Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID) (NCT06251492) | Fudan University | 2024-01-30 |
| Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma (NCT06105554) | M.D. Anderson Cancer Center | 2024-01-30 |
| A Study of Simmitinib Plus SG001 in Advanced Solid Tumors (NCT06132217) | Shanghai Runshi Pharmaceutical Technology Co., Ltd | 2024-01-30 |
| Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC (NCT05894889) | Peking University | 2024-01-30 |
| The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics (NCT06390787) | University of Baghdad | 2024-01-30 |
| A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma (NCT05955508) | Regeneron Pharmaceuticals | 2024-01-30 |
| Tucatinib+Trastuzumab+Eribulin in HER2+ MBC (NCT05458674) | Criterium, Inc. | 2024-01-30 |
| A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma (NCT06207305) | M.D. Anderson Cancer Center | 2024-01-30 |
| Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) (NCT06024824) | Cancer Trials Ireland | 2024-01-30 |
| Evaluating the Safety and Immunogenicity of MTBVAC (NCT05947890) | HIV Vaccine Trials Network | 2024-01-30 |
| Pilot Study on Trametinib for Surgical Unruptured AVMs (NCT06098872) | University Health Network, Toronto | 2024-01-30 |
| Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers (NCT06189638) | Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. | 2024-01-30 |
| Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN (NCT05743270) | Replimune, Inc. | 2024-01-30 |
| Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS) (NCT06189742) | Dr. Anne Ellis | 2024-01-29 |
| HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer (NCT06328387) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-01-29 |
| Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS) (NCT06334419) | Craig Erickson | 2024-01-29 |
| Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma (NCT07699185) | Tongji Hospital | 2024-01-29 |
| Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer (NCT05990543) | Korea University Anam Hospital | 2024-01-29 |
| Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations (NCT06279130) | The Netherlands Cancer Institute | 2024-01-29 |
| PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19 (NCT05954286) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2024-01-29 |
| CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children (NCT01344200) | Children's Hospital of Eastern Ontario | 2024-01-29 |
| Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness (NCT05968144) | University of Maryland, Baltimore | 2024-01-29 |
| Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease (NCT06046248) | Northside Hospital, Inc. | 2024-01-29 |
| Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine (NCT06294262) | LiteVax BV | 2024-01-29 |
| Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women (NCT06308614) | Estetra | 2024-01-29 |
| Study on TSR-042 in Advanced Clear Cell Sarcoma (NCT04274023) | Italian Sarcoma Group | 2024-01-29 |
| Feasibility of Semaglutide in Advanced Lung Disease (NCT05746039) | University of Pennsylvania | 2024-01-29 |
| A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NCT06262607) | Clexio Biosciences Ltd. | 2024-01-29 |
| A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors (NCT05956587) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-01-29 |
| Dog Presence and Oxytocin on Trust Towards Therapists (NCT06248710) | Dr. Karin Hediger | 2024-01-29 |
| Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50) (NCT06733051) | Sun Yat-sen University | 2024-01-27 |
| Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema (NCT06710249) | Peter Siesjö | 2024-01-27 |
| Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (NCT06072040) | Auregen Biotherapeutics, SA | 2024-01-26 |
| De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck (NCT06030440) | University of Erlangen-Nürnberg Medical School | 2024-01-26 |
| Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors (NCT06186726) | Jian Chen | 2024-01-26 |
| Decreasing Emergence Delirium With Personalized Music (NCT06236477) | Washington University School of Medicine | 2024-01-26 |
| Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201 (NCT06078566) | Auregen Biotherapeutics, SA | 2024-01-26 |
| Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC. (NCT06205472) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-01-26 |
| A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy (NCT06240598) | Memorial Sloan Kettering Cancer Center | 2024-01-26 |
| PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors (NCT06244992) | Pyrotech Therapeutics, Inc. | 2024-01-26 |
| A Clinical Study of T3011 in Subjects With Advanced Melanoma (NCT06214156) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-01-26 |
| Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia (NCT05816343) | University of Texas Southwestern Medical Center | 2024-01-26 |
| Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection (NCT05527418) | Eva Bonfill | 2024-01-26 |
| Study of Intra-articular Allocetra in Knee Osteoarthritis (NCT06233474) | Enlivex Therapeutics Ltd. | 2024-01-26 |